THMO: ThermoGenesis Holdings, Inc. Price to Sales

Symbol and logo of brand ThermoGenesis Holdings, Inc. (THMO)

ThermoGenesis leads the biobanking and stem cell processing sector. The company's smoothed P/S on GURU.Markets demonstrates market resilience, with the current metric standing at 0.10. Stability is ensured by sourcing components from proven suppliers and performing final assembly at its own facilities. Growth relies on the commercial storage of biomaterials for third-party laboratories without requiring significant investments.

THMO (ThermoGenesis Holdings) P/S Multiple history from 07/04/2022 to 08/04/2024

Analytical breakdowns for ThermoGenesis Holdings Inc. (THMO)

- market price and analyst price targets:
Stock Quotes thermogenesis.com|THMO - Analyst Consensus Forecast
- market capitalization information:
Market Value ThermoGenesis Holdings Inc.|THMO - Enterprise Value
- shareholders' equity book value data:
Equity per Share ThermoGenesis|THMO - Book Capitalization|Market Capitalization to Book Value thermogenesis.com|THMO - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio ThermoGenesis|THMO - Long-Term Debt to Capital|Short-Term Debt to Capital Cesca Therapeutics|THMO - Company Debts|Debt to Book Capitalization Ratio ThermoGenesis Holdings Inc.|THMO - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings ThermoGenesis|Immediate Liquidity thermogenesis.com
- net income and valuation multiples indicators:
THMO - Company Net Income|Projected Net Profit ThermoGenesis|THMO - Price to Earnings Ratio|Forward P/E Multiple ThermoGenesis Holdings, Inc.|THMO - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio ThermoGenesis Holdings Inc.|THMO - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months ThermoGenesis|THMO - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months thermogenesis.com|THMO - Earnings growth in current year|Expected net earnings per share growth next year ThermoGenesis
- issuer revenue and sales details:
THMO - Company Revenue|Company Revenue Forecast thermogenesis.com|THMO - Market Cap to Revenue|Price to Expected Revenue Ratio ThermoGenesis Holdings Inc.
Fundamental company analysis:thermogenesis.com THMO
Original product of ThermoGenesis Holdings Inc.

To minimize capital risks, investors analyze the ratio of market capitalization to annual sales volume. Given the role of ThermoGenesis (THMO) in creating infrastructure for biobanks and clinics, the price-to-sales valuation reveals how much the market is willing to pay for every dollar of revenue generated from the operation of this technological base, signaling whether the asset is overbought or undervalued relative to the sector.

Who ThermoGenesis competes with

Market Cap to Revenue abbott.com ABT|P/S Multiple TMO (Thermo Fisher)|GE HealthCare Technologies Inc. (GEHC) - Price to Sales|Mettler-Toledo International Inc. - P/S Multiple|WAT (Waters Technologies) - Market Cap to Revenue Ratio|TECH: P/S Multiple|BRKR - Price-to-Revenue Coefficient|AZTA (Azenta) - P/S Multiple|Market Cap to Revenue Varex Imaging Corp (VREX)|P/S Multiple SMLR|P/S Multiple Butterfly Corp (BFLY)|Price-to-Revenue Ratio Mesa Laboratories, Inc. MLAB|quantum-si.com - Price-to-Revenue Ratio|NNOX: Market Cap to Revenue|Market Capitalization-to-Revenue Ratio QTRX (Quanterix Corp.)|MASS: P/S Multiple|Price to Sales CapsoVision (CV)|Price-to-Revenue Ratio MaxCyte, Inc.|RPID - Price-to-Revenue Multiple|Market Cap to Revenue SEER (Seer)|P/S Multiple Hyperfine Inc (HYPR)|P/S Multiple FONR (FONAR Corp)|Price-to-Revenue Coefficient Daxor Corp (DXR)|MDAI - Price-to-Revenue Ratio|Price-to-Sales Ratio VIVS|Aclarion, Inc. (ACON) - Price-to-Revenue Ratio|Market Cap to Revenue Akoya Biosciences, Inc.|TLIS (Talis Biomedical Corp.) - P/S Multiple|Price to Sales T2 Biosystems Inc TTOO